$10.77
0.151.41%
At Close: -
$10.71
-0.06-0.56%
After Hours: 7:46 PM EDT
15 minutes delayed
Arcutis Biotherapeutics: Insider buying and selling updated today.
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
At Arcutis Biotherapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of - shares worth -, meanwhile, insiders have report no purchases in the last 30 days.
Jul 02, 2024 | Howard G Welgus | DIRECTOR | 0.00 | $5.50 | -$76.33K | SELL-OPTIONS | 0.00% | 205.33K | Jul 01 | View |
Jun 06, 2024 | Howard G Welgus | DIRECTOR | 0.00 | $4.84 | -$63.29K | SELL-OPTIONS | 0.00% | 195.19K | Jun 04 | View |
May 31, 2024 | Patrick Burnett | SEE REMARKS | -49.95K | $8.73 | -$636.71K | SELL | -19.23% | 209.79K | May 29 - May 30 | View |
May 29, 2024 | Masaru Matsuda | SEE REMARK | 3.10K | $9.01 | -$15.99K | GRANT | 1.67% | 188.51K | May 27 - May 28 | View |
May 20, 2024 | Larry Todd Edwards | SVP CHIEF COMMERCIAL OFFICER | 52.36K | $8.98 | -$68.58K | GRANT | 59.50% | 140.36K | May 16 - May 17 | View |
May 03, 2024 | Matthew Richard Moore | SVP AND CHIEF BUSINESS OFFICER | -515.00 | $8.74 | -$40.90K | SELL | -0.35% | 145.50K | May 01 - May 02 | View |
May 03, 2024 | Todd Franklin Watanabe | SEE REMARKS | -13.78K | $8.74 | -$120.43K | SELL | -1.38% | 985.71K | May 02 | View |
May 03, 2024 | Masaru Matsuda | SEE REMARK | -5.02K | $8.74 | -$43.83K | SELL | -2.63% | 185.41K | May 02 | View |
May 03, 2024 | Patrick Burnett | SEE REMARKS | -9.55K | $8.74 | -$83.49K | SELL | -3.55% | 259.75K | May 02 | View |
Mar 06, 2024 | Masaru Matsuda | SEE REMARK | -3.76K | $11.12 | -$41.82K | SELL | -1.94% | 190.42K | Mar 04 | View |
Mar 06, 2024 | Patrick Burnett | SEE REMARKS | -4.78K | $11.12 | -$53.18K | SELL | -1.74% | 269.30K | Mar 04 | View |
Mar 06, 2024 | Todd Franklin Watanabe | SEE REMARKS | -14.90K | $11.12 | -$165.74K | SELL | -1.57% | 931.89K | Mar 04 | View |
Mar 06, 2024 | Matthew Richard Moore | SVP AND CHIEF BUSINESS OFFICER | -3.47K | $11.12 | -$38.57K | SELL | -2.32% | 146.02K | Mar 04 | View |
Mar 06, 2024 | Patrick J Heron | — | 21.05K | $9.50 | $199.99K | BUY | 0.24% | 8.79M | Mar 04 | View |
Mar 01, 2024 | Todd Franklin Watanabe | SEE REMARKS | -2.46K | $10.60 | -$26.13K | SELL | -0.26% | 946.79K | Feb 28 | View |
Jan 03, 2024 | Patrick Burnett | SEE REMARKS | -1.32K | $3.54 | -$4.69K | SELL | -2.27% | 57.03K | Jan 02 | View |
Dec 01, 2023 | Todd Franklin Watanabe | SEE REMARKS | 60.99K | $1.79 | $109.37K | BUY | 11.92% | 572.50K | May 31 - Dec 01 | View |
Nov 21, 2023 | Masaru Matsuda | SEE REMARK | 3.02K | $1.98 | -$3.66K | GRANT | 6.94% | 46.63K | Nov 18 - Nov 21 | View |
Oct 26, 2023 | Frazier Life Sciences VIII LPFHM LIFE SCIENCES VIII LPFHM LIFE SCIENCES VIII LLCJames TopperPatrick Heron | DIRECTOR | 80.00K | $2.50 | $200.00K | BUY | 0.92% | 8.77M | Oct 24 | View |
Aug 22, 2023 | Patrick Burnett | SEE REMARKS | -1.60K | $7.04 | -$11.30K | SELL | -2.68% | 58.36K | Aug 21 | View |
Jun 02, 2023 | Masaru Matsuda | SEE REMARK | 4.51K | $7.09 | -$4.94K | GRANT | 11.53% | 43.61K | May 27 - May 31 | View |
Apr 18, 2023 | Howard G Welgus | DIRECTOR | 0.00 | $7.82 | -$104.44K | SELL-OPTIONS | 0.00% | 190.82K | Apr 17 | View |
Apr 10, 2023 | Howard G Welgus | DIRECTOR | 0.00 | $6.85 | -$87.80K | SELL-OPTIONS | 0.00% | 190.82K | Apr 06 | View |
Mar 08, 2023 | Todd Franklin Watanabe | SEE REMARKS | -2.44K | $15.26 | -$37.17K | SELL | -0.57% | 424.01K | Mar 06 | View |
Mar 08, 2023 | Scott L Burrows | CHIEF FINANCIAL OFFICER | -291.00 | $15.26 | -$4.44K | SELL | -0.49% | 59.12K | Mar 06 | View |
Mar 08, 2023 | Patrick Burnett | SEE REMARKS | -851.00 | $15.26 | -$12.99K | SELL | -1.40% | 59.96K | Mar 06 | View |
Mar 08, 2023 | Patricia A Turney | SVP, OPERATIONS | -831.00 | $15.26 | -$12.68K | SELL | -1.30% | 62.86K | Mar 06 | View |
Mar 08, 2023 | David W Osborne | CHIEF TECHNICAL OFFICER | -690.00 | $15.26 | -$10.53K | SELL | -0.26% | 268.85K | Mar 06 | View |
Mar 08, 2023 | Kenneth A Lock | CHIEF COMMERCIAL OFFICER | -831.00 | $15.26 | -$12.68K | SELL | -1.29% | 63.43K | Mar 06 | View |
Mar 06, 2023 | Matthew Richard Moore | SEE REMARKS | 13.29K | $15.83 | -$25.48K | GRANT | 99.92% | 26.59K | Mar 02 | View |
Mar 06, 2023 | Matsuda Masaru | SEE REMARKS | 19.57K | $15.83 | -$22.70K | GRANT | 100.16% | 39.10K | Mar 02 | View |
Mar 06, 2023 | Patrick Burnett | SEE REMARKS | 19.25K | $15.83 | -$27.71K | GRANT | 46.31% | 60.81K | Mar 02 | View |
Mar 02, 2023 | Patricia A Turney | SVP, OPERATIONS | -2.37K | $15.96 | -$37.80K | SELL | -4.93% | 45.69K | Feb 28 - Mar 02 | View |
Mar 02, 2023 | Todd Franklin Watanabe | SEE REMARKS | -7.82K | $15.93 | -$124.48K | SELL | -1.80% | 426.45K | Feb 28 - Mar 02 | View |
Mar 02, 2023 | Scott L Burrows | CHIEF FINANCIAL OFFICER | -1.85K | $15.90 | -$29.42K | SELL | -4.60% | 38.41K | Feb 28 - Mar 02 | View |
Mar 02, 2023 | Kenneth A Lock | CHIEF COMMERCIAL OFFICER | -2.37K | $15.96 | -$37.80K | SELL | -5.19% | 43.26K | Feb 28 - Mar 02 | View |
Mar 02, 2023 | David W Osborne | CHIEF TECHNICAL OFFICER | -2.00K | $15.96 | -$32.00K | SELL | -0.78% | 254.64K | Feb 28 - Mar 02 | View |
Feb 21, 2023 | Howard G Welgus | DIRECTOR | 0.00 | $9.33 | -$130.07K | SELL-OPTIONS | 0.00% | 190.82K | Feb 15 | View |
Feb 15, 2023 | Todd Franklin Watanabe | SEE REMARKS | -1.00K | $17.01 | -$17.01K | SELL | -0.23% | 434.26K | Feb 13 - Feb 14 | View |
Feb 03, 2023 | Todd Franklin Watanabe | SEE REMARKS | -1.00K | $17.00 | -$17.00K | SELL | -0.23% | 435.26K | Feb 01 | View |
Jan 18, 2023 | Howard G Welgus | DIRECTOR | 0.00 | $7.70 | -$102.37K | SELL-OPTIONS | 0.00% | 190.82K | Jan 17 | View |
Jan 04, 2023 | Patrick Burnett | SEE REMARKS | -1.48K | $15.01 | -$22.14K | SELL | -3.43% | 41.56K | Jan 03 | View |
Dec 09, 2022 | Todd Franklin Watanabe | SEE REMARKS | -1.00K | $17.06 | -$17.06K | SELL | -0.20% | 503.86K | Dec 07 | View |
Nov 22, 2022 | Matsuda Masaru | SEE REMARK | 3.15K | $18.19 | -$31.29K | GRANT | 19.26% | 19.54K | Nov 18 - Nov 21 | View |
Nov 17, 2022 | Howard G Welgus | DIRECTOR | -2.38K | $10.85 | -$66.39K | SELL | -1.23% | 190.82K | Nov 15 | View |
Nov 09, 2022 | Todd Franklin Watanabe | SEE REMARKS | -1.00K | $18.00 | -$18.00K | SELL | -0.20% | 504.86K | Nov 07 | View |
Oct 11, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | -1.00K | $19.51 | -$19.51K | SELL | -0.20% | 505.86K | Oct 07 | View |
Oct 06, 2022 | Howard G Welgus | DIRECTOR | -6.00K | $20.29 | -$121.77K | SELL | -3.01% | 193.20K | Oct 04 | View |
Sep 09, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | -269.96K | $21.51 | -$21.51K | SELL | -34.75% | 506.86K | Jun 23 - Sep 07 | View |
Aug 17, 2022 | Howard G Welgus | DIRECTOR | -6.00K | $24.80 | -$148.79K | SELL | -2.92% | 199.20K | Aug 15 | View |
Aug 09, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $13.21 | -$57.66K | SELL-OPTIONS | 0.00% | 776.83K | Aug 05 | View |
Aug 09, 2022 | Frazier Life Sciences VIII LPFHM LIFE SCIENCES VIII LPFHM LIFE SCIENCES VIII LLCJames TopperPatrick Heron | DIRECTOR | 250.00K | $20.00 | $5.00M | BUY | 2.96% | 8.71M | Aug 05 | View |
Jul 18, 2022 | Howard G Welgus | DIRECTOR | -6.00K | $24.40 | -$146.37K | SELL | -2.84% | 205.20K | Jul 18 | View |
Jul 12, 2022 | David W Osborne | CHIEF TECHNICAL OFFICER | -2.20K | $25.41 | -$55.84K | SELL | -0.85% | 256.65K | Jul 08 | View |
Jul 12, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | -6.41K | $13.52 | -$330.56K | SELL | -0.82% | 776.83K | Jul 08 | View |
Jul 07, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | -1.00K | $22.07 | -$22.07K | SELL | -0.13% | 783.24K | Jul 06 | View |
Jun 28, 2022 | ORBIMED ADVISORS LLCORBIMED CAPITAL LLCOrbiMed Capital GP VII LLC | 10% OWNER | -341.97K | $21.31 | -$7.29M | SELL | -45.17% | 415.14K | Jun 24 | View |
Jun 06, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | -1.00K | $21.06 | -$21.06K | SELL | -0.13% | 784.24K | Jun 06 | View |
Jun 02, 2022 | Matsuda Masaru | SVP AND GENERAL COUNSEL | 3.08K | $19.73 | -$35.42K | GRANT | 23.16% | 16.38K | May 27 - Jun 02 | View |
Jun 02, 2022 | Howard G Welgus | DIRECTOR | 0.00 | $11.15 | -$47.34K | SELL-OPTIONS | 0.00% | 206.89K | Jun 01 | View |
May 05, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | -1.00K | $21.76 | -$21.76K | SELL | -0.13% | 783.62K | May 05 | View |
May 03, 2022 | Howard G Welgus | DIRECTOR | 0.00 | $10.73 | -$48.56K | SELL-OPTIONS | 0.00% | 206.89K | May 02 | View |
Apr 21, 2022 | David W Osborne | CHIEF TECHNICAL OFFICER | -2.20K | $20.42 | -$44.87K | SELL | -0.85% | 257.23K | Apr 21 | View |
Apr 08, 2022 | ORBIMED ADVISORS LLCORBIMED CAPITAL LLCOrbiMed Capital GP VII LLC | 10% OWNER | -878.20K | $20.68 | -$18.16M | SELL | -66.07% | 451.09K | Apr 06 - Apr 08 | View |
Apr 05, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | -1.00K | $21.43 | -$21.43K | SELL | -0.13% | 784.62K | Apr 05 | View |
Apr 01, 2022 | Howard G Welgus | DIRECTOR | 0.00 | $10.30 | -$145.83K | SELL-OPTIONS | 0.00% | 206.89K | Apr 01 | View |
Mar 11, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | -300.00 | $17.00 | -$5.10K | SELL | -0.04% | 785.62K | Mar 09 | View |
Mar 07, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | 68.34K | $9.29 | -$53.91K | SELL-OPTIONS | 9.52% | 785.92K | Mar 03 - Mar 07 | View |
Mar 07, 2022 | Patrick Burnett | SEE REMARKS | 16.79K | $16.85 | -$17.03K | GRANT | 63.96% | 43.04K | Mar 03 - Mar 07 | View |
Mar 07, 2022 | Kenneth A Lock | CHIEF COMMERCIAL OFFICER | 12.28K | $16.85 | -$17.23K | GRANT | 38.69% | 44.01K | Mar 03 - Mar 07 | View |
Mar 07, 2022 | Scott L Burrows | CHIEF FINANCIAL OFFICER | 13.00K | $16.85 | -$5.10K | GRANT | 58.39% | 35.26K | Mar 03 - Mar 07 | View |
Mar 07, 2022 | Patricia A Turney | SVP, OPERATIONS | 12.28K | $16.85 | -$17.23K | GRANT | 65.18% | 31.11K | Mar 03 - Mar 07 | View |
Mar 07, 2022 | David W Osborne | CHIEF TECHNICAL OFFICER | 12.44K | $16.85 | -$14.42K | GRANT | 5.04% | 259.43K | Mar 03 - Mar 07 | View |
Mar 03, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | -2.15K | $17.75 | -$38.22K | SELL | -0.30% | 717.58K | Mar 01 | View |
Mar 03, 2022 | David W Osborne | CHIEF TECHNICAL OFFICER | -775.00 | $17.75 | -$13.76K | SELL | -0.31% | 246.98K | Mar 01 | View |
Mar 03, 2022 | Scott L Burrows | CHIEF FINANCIAL OFFICER | -420.00 | $17.75 | -$7.46K | SELL | -1.85% | 22.26K | Mar 01 | View |
Mar 03, 2022 | Patricia A Turney | SVP, OPERATIONS | -936.00 | $17.75 | -$16.62K | SELL | -4.73% | 18.84K | Mar 01 | View |
Mar 03, 2022 | Kenneth A Lock | CHIEF COMMERCIAL OFFICER | -935.00 | $17.75 | -$16.60K | SELL | -2.86% | 31.73K | Mar 01 | View |
Feb 11, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $9.34 | -$15.32K | SELL-OPTIONS | 0.00% | 719.74K | Feb 09 | View |
Jan 07, 2022 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $11.64 | -$19.91K | SELL-OPTIONS | 0.00% | 719.74K | Jan 05 | View |
Jan 05, 2022 | Howard G Welgus | DIRECTOR | 0.00 | $10.90 | -$51.58K | SELL-OPTIONS | 0.00% | 206.89K | Jan 03 | View |
Dec 28, 2021 | Scott L Burrows | CHIEF FINANCIAL OFFICER | -12.56K | $20.07 | -$252.14K | SELL | -35.64% | 22.68K | Dec 27 | View |
Dec 23, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $10.37 | -$48.95K | SELL-OPTIONS | 0.00% | 206.89K | Dec 23 | View |
Dec 10, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $9.34 | -$15.32K | SELL-OPTIONS | 0.00% | 719.74K | Dec 08 | View |
Nov 09, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $11.59 | -$19.82K | SELL-OPTIONS | 0.00% | 719.74K | Nov 05 | View |
Nov 03, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $11.19 | -$53.07K | SELL-OPTIONS | 0.00% | 206.89K | Nov 01 | View |
Oct 07, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $13.30 | -$58.09K | SELL-OPTIONS | 0.00% | 719.74K | Oct 05 | View |
Oct 05, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $12.23 | -$58.23K | SELL-OPTIONS | 0.00% | 206.89K | Oct 01 | View |
Oct 05, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $13.34 | -$34.99K | SELL-OPTIONS | 0.00% | 719.74K | Oct 01 | View |
Sep 09, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $11.41 | -$19.46K | SELL-OPTIONS | 0.00% | 719.74K | Sep 07 | View |
Sep 03, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $11.18 | -$96.20K | SELL-OPTIONS | 0.00% | 206.89K | Sep 01 | View |
Aug 09, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $11.25 | -$19.13K | SELL-OPTIONS | 0.00% | 719.74K | Aug 05 | View |
Jul 08, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $14.13 | -$43.57K | SELL-OPTIONS | 0.00% | 719.74K | Jul 06 | View |
Jul 06, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $15.03 | -$48.80K | SELL-OPTIONS | 0.00% | 206.89K | Jul 01 | View |
Jun 28, 2021 | Bhaskar Chaudhuri | DIRECTOR | -7.48K | $27.50 | -$205.81K | SELL | -0.83% | 891.37K | Jun 24 - Jun 25 | View |
Jun 23, 2021 | Bhaskar Chaudhuri | DIRECTOR | -2.52K | $27.50 | -$69.19K | SELL | -0.28% | 898.86K | Jun 21 | View |
Jun 09, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $14.02 | -$43.17K | SELL-OPTIONS | 0.00% | 719.74K | Jun 07 | View |
Jun 03, 2021 | Bhaskar Chaudhuri | DIRECTOR | -10.00K | $27.50 | -$275.00K | SELL | -1.10% | 901.37K | Jun 01 | View |
Jun 03, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $15.52 | -$50.92K | SELL-OPTIONS | 0.00% | 237.54K | Jun 01 | View |
May 11, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $18.34 | -$24.99K | SELL-OPTIONS | 0.00% | 718.73K | May 07 | View |
May 07, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | -143.00 | $17.84 | -$56.80K | SELL | -0.02% | 718.73K | May 05 | View |
May 05, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $19.37 | -$67.87K | SELL-OPTIONS | 0.00% | 235.93K | May 03 | View |
May 04, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | -1.50K | $35.00 | -$52.50K | SELL | -0.21% | 718.87K | Apr 30 | View |
Apr 22, 2021 | Bhaskar Chaudhuri | DIRECTOR | -10.00K | $28.06 | -$280.57K | SELL | -1.09% | 911.37K | Apr 20 | View |
Apr 06, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | -1.75K | $29.93 | -$52.38K | SELL | -0.24% | 720.37K | Apr 05 | View |
Apr 05, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $16.72 | -$56.20K | SELL-OPTIONS | 0.00% | 233.28K | Apr 01 | View |
Mar 24, 2021 | Bhaskar Chaudhuri | DIRECTOR | -10.00K | $31.10 | -$311.02K | SELL | -1.07% | 921.37K | Mar 22 | View |
Mar 11, 2021 | John W Smither | CHIEF FINANCIAL OFFICER | -1.25K | $17.29 | -$56.73K | SELL | -1.42% | 86.72K | Mar 10 | View |
Mar 05, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 30.95K | $30.55 | -$53.46K | GRANT | 4.48% | 722.12K | Mar 03 - Mar 05 | View |
Mar 03, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | -2.11K | $35.19 | -$74.14K | SELL | -0.30% | 691.17K | Mar 02 | View |
Mar 03, 2021 | David W Osborne | CHIEF TECHNICAL OFFICER | -780.00 | $34.57 | -$26.97K | SELL | -0.33% | 237.25K | Mar 01 | View |
Mar 03, 2021 | Patricia A Turney | SVP, OPERATIONS | -934.00 | $34.52 | -$32.24K | SELL | -9.15% | 9.27K | Mar 01 | View |
Mar 03, 2021 | John W Smither | CHIEF FINANCIAL OFFICER | -773.00 | $34.20 | -$26.44K | SELL | -0.68% | 112.39K | Mar 01 | View |
Mar 03, 2021 | Kenneth A Lock | CHIEF COMMERCIAL OFFICER | -933.00 | $34.20 | -$31.91K | SELL | -4.04% | 22.17K | Mar 01 | View |
Mar 03, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $19.14 | -$66.98K | SELL-OPTIONS | 0.00% | 230.62K | Mar 01 | View |
Feb 24, 2021 | Bhaskar Chaudhuri | DIRECTOR | -10.00K | $35.52 | -$355.19K | SELL | -1.06% | 931.37K | Feb 22 | View |
Feb 12, 2021 | John W Smither | CHIEF FINANCIAL OFFICER | -2.00K | $18.66 | -$96.75K | SELL | -2.22% | 87.97K | Feb 10 | View |
Feb 08, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $17.99 | -$326.11K | SELL-OPTIONS | 0.00% | 693.28K | Feb 05 | View |
Feb 03, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $18.02 | -$71.87K | SELL-OPTIONS | 0.00% | 208.11K | Feb 01 | View |
Feb 03, 2021 | John W Smither | CHIEF FINANCIAL OFFICER | -3.75K | $18.34 | -$172.90K | SELL | -4.00% | 89.97K | Feb 01 | View |
Feb 02, 2021 | Bhaskar Chaudhuri | DIRECTOR | -10.00K | $33.22 | -$332.21K | SELL | -1.05% | 941.37K | Jan 29 - Feb 01 | View |
Jan 21, 2021 | John W Smither | CHIEF FINANCIAL OFFICER | -1.25K | $15.84 | -$51.66K | SELL | -1.32% | 93.72K | Jan 19 | View |
Jan 07, 2021 | Todd Franklin Watanabe | PRESIDENT AND CEO | 0.00 | $15.84 | -$84.96K | SELL-OPTIONS | 0.00% | 691.88K | Sep 29 | View |
Jan 06, 2021 | Howard G Welgus | DIRECTOR | 0.00 | $14.75 | -$57.52K | SELL-OPTIONS | 0.00% | 206.89K | Jan 04 | View |
Dec 16, 2020 | David W Osborne | — | -15.00K | $30.00 | -$450.00K | SELL | -4.57% | 313.01K | Dec 14 | View |
Dec 16, 2020 | John W Smither | — | -3.75K | $15.84 | -$154.98K | OPTION EXERCISE | -3.80% | 94.97K | Dec 14 | View |
Dec 03, 2020 | Howard G Welgus | — | 0.00 | $13.83 | -$53.46K | OPTION EXERCISE | 0.00% | 204.84K | Dec 01 | View |
Nov 04, 2020 | Howard G Welgus | — | 0.00 | $9.97 | -$36.49K | OPTION EXERCISE | 0.00% | 203.61K | Nov 02 | View |
Oct 06, 2020 | ORBIMED ADVISORS LLCORBIMED CAPITAL LLCOrbiMed Capital GP VII LLC | — | 496.00K | $25.00 | $12.40M | PURCHASE | 122.08% | 902.29K | Oct 02 | View |
Oct 06, 2020 | Jonathan Silverstein | — | 496.00K | $25.00 | $12.40M | PURCHASE | 122.08% | 902.29K | Oct 02 | View |
Oct 05, 2020 | Howard G Welgus | — | 0.00 | $14.66 | -$57.13K | OPTION EXERCISE | 0.00% | 202.39K | Oct 01 | View |
Oct 01, 2020 | Todd Franklin Watanabe | — | 0.00 | $15.84 | -$84.96K | OPTION EXERCISE | 0.00% | 691.88K | Sep 29 | View |
Oct 01, 2020 | David W Osborne | — | -15.00K | $30.00 | -$450.00K | SELL | -4.39% | 326.76K | Sep 29 | View |
Oct 01, 2020 | John W Smither | — | -1.25K | $15.84 | -$51.66K | OPTION EXERCISE | -1.25% | 98.72K | Sep 29 | View |
Sep 02, 2020 | Howard G Welgus | — | 0.00 | $13.03 | -$49.95K | OPTION EXERCISE | 0.00% | 201.17K | Sep 01 | View |
Aug 05, 2020 | Howard G Welgus | — | 0.00 | $13.66 | -$67.06K | OPTION EXERCISE | 0.00% | 184.98K | Aug 03 | View |
Feb 06, 2020 | Bain Capital Life Sciences Investors LLCBain Capital Life Sciences Partners LPBain Capital Life Sciences Fund LPBCIP Life Sciences Associates LPAdam KoppelLawrence Jeffrey Schwartz | — | 3.98M | $17.00 | $5.00M | DERIVATIVE CONVERSION | ∞ | 3.98M | Feb 04 | View |
Feb 06, 2020 | Patrick J Heron | — | 10.03M | $17.00 | $8.50M | DERIVATIVE CONVERSION | 1971.14% | 10.54M | Feb 04 | View |
Feb 06, 2020 | Frazier Life Sciences VIII LPFHM LIFE SCIENCES VIII LPFHM LIFE SCIENCES VIII LLCJames Topper | — | 10.03M | $17.00 | $8.50M | DERIVATIVE CONVERSION | 1971.14% | 10.54M | Feb 04 | View |
Feb 04, 2020 | ORBIMED ADVISORS LLCORBIMED CAPITAL LLCOrbiMed Capital GP VII LLC | — | 4.67M | $17.00 | $9.50M | DERIVATIVE CONVERSION | ∞ | 606.29K | Feb 03 - Feb 04 | View |
Feb 04, 2020 | Jonathan Silverstein | — | 4.67M | $17.00 | $9.50M | DERIVATIVE CONVERSION | ∞ | 606.29K | Feb 03 - Feb 04 | View |
Browse insider trades on all stocks.